Weisbach L, Schuster AK, Hartmann M, Dürr P, Then M, Andrikyan W, Fromm M, Maas R, Farker K (2023)
Publication Type: Journal article, Original article
Publication year: 2023
Book Volume: 89
Pages Range: 2552-2560
Journal Issue: 8
DOI: 10.1111/bcp.15730
Aims: Prescribing information should follow a defined structure to help prescribers easily find required information. Often information appears in different sections of Summaries of Product Characteristics (SmPCs) in an inconsistent way. Still unknown is how this inconsistency affects absolute contraindications and how it can be improved. Thisstudy aimed to evaluate the structure of absolute contraindications in SmPCs based on absolute drug-drug contraindications (DDCI) in the section 'contraindications' and references to sections 'special warnings and precautions for use' (here as 'warnings') and 'interaction with other medicinal products and other forms of interaction' (here as 'interactions').
APA:
Weisbach, L., Schuster, A.K., Hartmann, M., Dürr, P., Then, M., Andrikyan, W.,... Farker, K. (2023). Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs. British Journal of Clinical Pharmacology, 89(8), 2552-2560. https://doi.org/10.1111/bcp.15730
MLA:
Weisbach, Laura, et al. "Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs." British Journal of Clinical Pharmacology 89.8 (2023): 2552-2560.
BibTeX: Download